Matthew Levitus
Iyad Kejo
Manoj Lal Karwa
Joseph J. Hong
Patricia A. Hametz
Dr. Hametz's clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.
Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families.
<p>Patricia A. Hametz, MD, MPH, is Chief of the Division of Pediatric Hospital Medicine at Children’s Hospital at Montefiore Einstein (CHAM). As Chief, she oversees the care of children admitted to the general pediatrics service, consultation service and co-management of patients on the pediatric surgery and surgical subspecialty services. She is also an Attending Physician at CHAM and an Associate Professor of Pediatrics at Albert Einstein College of Medicine. Her clinical focus is on providing family-centered care for all hospitalized children and on developing and implementing systems of care for children with medical complexities.</p><p>Dr. Hametz received her Doctor of Medicine in 1995 from Columbia University College of Physicians and Surgeons in New York. In 2008, she received her Master of Public Health from Columbia University Mailman School of Public Health. Dr. Hametz completed an internship and residency in Pediatrics at Morgan Stanley Children's Hospital of New York from 1995 to 1999 and became Chief Resident in 1998.</p><p>Dr. Hametz’s research focuses on improving care and the systems in which care is provided to hospitalized children and adolescents, and their families. Her original communications have been published in numerous peer-reviewed journals, as well as invited publications. She has been an invited speaker to regional and local presentations.</p><p>Dr. Hametz has been recognized as an outstanding teacher, was nominated for the Attending Teacher of the Year Award several times and also won the Pediatric Residency Appreciation Award in 2015. Dr. Hametz is board certified by the American Board of Pediatrics and is a Resident Member of the American Academy of Pediatrics.</p>
David L. Goldman
<p>The medical community has long recognized fungi as important allergens for patients with asthma. Interestingly, fungal sensitization is more common in children and has been linked to severe asthma resulting in death. The accepted paradigm is that fungal sensitization occurs as a result of recurrent, transient environmental exposures. Yet, increasing evidence suggests that fungi may interact with people in unrecognized ways to promote asthma. My lab is interested in understanding the role of subclinical fungal infections in asthma and their potential contribution to the high prevalence of asthma in urban areas.<br /><br /></p>
<p><em>Cryptococcus neoformans</em> is an encapsulated fungus that is well suited to serve as co-factor in urban asthma. <em>C. neoformans</em> colonizes pigeon droppings and is endemic to urban areas. Once inhaled, this fungus causes persistent, subclinical infections. We have demonstrated that the majority of Bronx children older than 2 years have serologic evidence of cryptococcal infection. Cryptococcal infection induces TH2 inflammation in animal models. In a rat model, we have shown that cryptococcal pulmonary infection acts a co-factor to enhance allergic inflammation to allergen challenge and promotes airway hyper-responsiveness, both hallmark features of asthma. Pulmonary cryptococcosis also induces chitinase expression, which has recently been implicated as an essential mediator of allergic inflammation.<br /><br /></p>
<p>To study this phenomenon, we have established collaborations with Pulmonary Medicine, Critical Care and Emergency Medicine at the Children’s Hospital of Montefiore. These collaborations provide access to the large number of children with asthma in the Bronx. Current studies underway include a characterization of chitinase expression among asthmatics and a comparison of cryptococcal infection prevalence among asthmatics and non-asthmatics. Animal experimentation directed at understanding the mechanisms and variables related to fungal induced asthma are also underway.<br /><br /></p>
<p>In addition to fungal studies, my lab is interested in anthrax pathogenesis. <em>Bacillus anthracis</em> is widely recognized as a potential agent of bioterrorism as evidenced by the 2001 anthrax attack. The toxins of <em>B. anthracis</em> are essential to virulence. In collaborations with Drs. Arturo Casadevall and Jurgen Brojatsch, we have studied the mechanisms by which <em>Bacillus anthracis</em> toxins contribute to host death. We have identified a previously unrecognized protease in human serum that inactivates the protective antigen component of lethal toxin <em>in vitro</em>. The precise protease and its role in the host response and susceptibility to anthrax remain to be determined. We have also identified a potential role for platelet activating factor (PAF) in mediating the lethal effects of toxin, including the alterations in vascular permeability which is characteristic of anthrax. Together, these observations may have important implications in developing new approaches to the treatment of anthrax.</p>
Dr. Goldman has a special interest in fungal infections in children, including hospital and community acquired mycoses.
Dr. Goldman has two primary research interests: the contribution of fungi to the development of asthma in children and the pathogenesis of C. difficile infection in children
<div id="pmid_19708853" class="rprt">
<div class="rprtNum"> </div>
<br /> </div>
<p>1. Fungal sensitization in childhood persistent asthma is associated with disease severity. Vicencio AG, Santiago MT, Tsirilakis K, Stone A, Worgall S, Foley EA, Bush D, Goldman DL. Pediatr Pulmonol. 2013 Feb 8. doi: 10.1002/ppul.22779. [Epub ahead of print]</p>
<p> </p>
<p>2. Increased chitinase expression and fungal-specific antibodies in the bronchoalveolar lavage fluid of asthmatic children. Goldman DL, Li X, Tsirilakis K, Andrade C, Casadevall A, Vicencio AG. Clin Exp Allergy. 2012 Apr;42(4):523-30. doi: 10.1111/j.1365-2222.2011.03886.x. Epub 2011 Oct 10.</p>
<p> </p>
<p>3. CHIT1 mutations: genetic risk factor for severe asthma with fungal sensitization? Vicencio AG, Chupp GL, Tsirilakis K, He X, Kessel A, Nandalike K, Veler H, Kipperman S, Young MC, Goldman DL.</p>
<p>Pediatrics. 2010 Oct;126(4):e982-5. doi: 10.1542/peds.2010-0321. Epub 2010 Sep 6.</p>
<p> </p>
<p>4. Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin.Muehlbauer SM, Lima H Jr, Goldman DL, Jacobson LS, Rivera J, Goldberg MF, Palladino MA, Casadevall A, Brojatsch J. Am J Pathol. 2010 Aug;177(2):735-43. doi: 10.2353/ajpath.2010.090828. Epub 2010 Jul 1. Erratum in: Am J Pathol. 2010 Oct;177(4):2145.</p>
<p> </p>
<p>David L. Goldman, MD, is Fellowship Director, Pediatric Infectious Diseases; Associate Professor, Pediatrics, and Associate Professor, Microbiology and Infectious Diseases at Montefiore Einstein. He has a special interest in fungal infections in children, including hospital and community acquired mycoses.</p><p>After earning his Bachelor of Arts from Brandeis University in 1983, Dr. Goldman attended Jefferson Medical College, earning his Doctor of Medicine in 1987. He began his postdoctoral education at St. Vincent’s Hospital. Yale University, New York Medical College, completing a yearlong internship before coming to Einstein’s Jacobi Medical Center, where he completed a residency in pediatrics in 1991, a fellowship in academic pediatrics in 1992 and a fellowship in pediatric infectious diseases in 1996.</p><p>Dr. Goldman has two primary research interests: the contribution of fungi to the development of asthma in children and the pathogenesis of C. difficile infection in children. He has shared his work through conferences, symposia, books, peer-reviewed journals, review articles, abstracts and poster presentations. He has also been an ad hoc reviewer for several journals including <em>Infection and Immunity, Microbes and Infection</em>, and <em>Medical Mycology</em>.</p><p>Dr. Goldman is board certified in pediatrics and pediatric infectious diseases. He is a member of the American Society of Microbiology, the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society.</p>
Cache M. Giacalone
Howard Geyer
<p>Dr. Howard Geyer is Director, Division of Movement Disorders, Montefiore, and Assistant Professor, Neurology, Albert Einstein College of Medicine. He received his MD and PhD degrees from the University of Pennsylvania. He was chief resident in Neurology at Montefiore, where he also completed a fellowship in Clinical Neurophysiology. He completed an additional fellowship in Movement Disorders at Beth Israel Medical Center. Dr. Geyer regularly lectures and contributes to book chapters and journal articles on a variety of neurologic topics.</p>
Benjamin T. Galen
<p>Dr. Galen graduated from Brown University with honors in the biological sciences and earned an M.D. from Tufts University School of Medicine. He trained in internal medicine at Yale University where he was elected to the Gold Humanism Honor Society and was the class speaker at residency graduation. He joined Montefiore and Einstein in 2013 as a teaching attending in Hospital Medicine</p>
<p>Dr. Galen is an Associate Program Director in The Einstein/Montefiore Internal Medicine Residency Program, the Director of Firm 3 and the Director of ultrasound and procedure training. In 2015 Dr. Galen received the Sharon R. Silbiger Faculty Teaching Award from the Einstein residents. He has led hundreds of resident teaching conferences and has worked to formalize curricula for point-of-care ultrasound (POCUS) and bedside procedures, such as lumbar puncture and paracentesis. Dr. Galen has taught in the EPHEM, Microbiology, and PDC classes at Einstein. He has led translational research on recurrent meningitis, collaborting with members of Betsy Herold's laboratory. He has co-authored over 20 original research studies. Dr. Galen is passionate about medical case reports and he has mentored residents and junior faculty in the process of publishing cases in a variety of venues. </p>
<p>Dr. Galen is the editor-in-chief of <em>POCUS Journal (</em><a href="https://pocusjournal.com/">https://pocusjournal.com/)</a>, the world's leading peer-reviewed, open-access publication for point-of-care ultrasound. He teaches POCUS nationally at a variety of workshops and conferences. </p>
<ol>
<li>Shankar, N., Kuo, L., Krugliak Cleveland, N., Galen, B., Samel, N. S., Perez-Sanchez, A., Nathanson, R., Coss, E., Echavarria, J., Rubin, D. T., & Soni, N. J. (2025). Point-of-Care Ultrasound in Gastroenterology and Hepatology. <em>Clin Gastroenterol Hepatol</em>. <a href="https://doi.org/10.1016/j.cgh.2024.09.040" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.cgh.2024.09.040</a></li>
<li>Cool, J. A., Galen, B. T., & Dancel, R. (2025). Point-counterpoint: Should hospitalists perform their own bedside procedures? <em>J Hosp Med</em>,<em> 20</em>(1), 89-93. <a href="https://doi.org/10.1002/jhm.13545" target="_blank" rel="noopener noreferrer">https://doi.org/10.1002/jhm.13545</a></li>
<li>Schechter, M. S., Baron, S. W., Gohari, A., Southern, W. N., & Galen, B. T. (2024). Midline Catheter-Associated Thrombosis (MCAT): Does Tip Location in the Axillary Vein Increase Risk? <em>J Infus Nurs</em>,<em> 47</em>(6), 363-368. <a href="https://doi.org/10.1097/nan.0000000000000558" target="_blank" rel="noopener noreferrer">https://doi.org/10.1097/nan.0000000000000558</a></li>
<li>Singh, J., Oliver-Krasinski, J., Tauras, J., & Galen, B. T. (2023). Systemic Amyloidosis: Is It ATTR or AL? <em>Am J Med</em>,<em> 136</em>(7), 652-654. <a href="https://doi.org/10.1016/j.amjmed.2023.03.009" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.amjmed.2023.03.009</a></li>
<li>Johri, A. M., Glass, C., Hill, B., Jensen, T., Puentes, W., Olusanya, O., Capizzano, J. N., Dancel, R., Reierson, K., Reisinger, N., Liblik, K., & Galen, B. T. (2023). The Evolution of Cardiovascular Ultrasound: A Review of Cardiac Point-of-Care Ultrasound (POCUS) Across Specialties. <em>Am J Med</em>,<em> 136</em>(7), 621-628. <a href="https://doi.org/10.1016/j.amjmed.2023.02.020" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.amjmed.2023.02.020</a></li>
<li>Eman, G., Synn, S., Galen, B., Shah, R., Nauka, P., Hope, A. A., Congdon, S., & Islam, M. (2023). Thoracic Ultrasound in COVID-19: Use of Lung and Diaphragm Ultrasound in Evaluating Dyspnea in Survivors of Acute Respiratory Distress Syndrome from COVID-19 Pneumonia in a Post-ICU Clinic. <em>Lung</em>,<em> 201</em>(2), 149-157. <a href="https://doi.org/10.1007/s00408-023-00614-w" target="_blank" rel="noopener noreferrer">https://doi.org/10.1007/s00408-023-00614-w</a></li>
<li>Nauka, P. C., LeFrancois, D., & Galen, B. T. (2022). An Introductory Curriculum for Internal Medicine Interns in Point-of-Care Ultrasound to Detect Lower Extremity Deep Vein Thrombosis. <em>Pocus j</em>,<em> 7</em>(2), 185-186. <a href="https://doi.org/10.24908/pocus.v7i2.15937" target="_blank" rel="noopener noreferrer">https://doi.org/10.24908/pocus.v7i2.15937</a></li>
<li>Varrias, D., Palaiodimos, L., Balasubramanian, P., Barrera, C. A., Nauka, P., Melainis, A. A., Zamora, C., Zavras, P., Napolitano, M., Gulani, P., Ntaios, G., Faillace, R. T., & Galen, B. (2021). The Use of Point-of-Care Ultrasound (POCUS) in the Diagnosis of Deep Vein Thrombosis. <em>J Clin Med</em>,<em> 10</em>(17). <a href="https://doi.org/10.3390/jcm10173903" target="_blank" rel="noopener noreferrer">https://doi.org/10.3390/jcm10173903</a></li>
<li>Shah, R., Zhang, L., & Galen, B. T. (2021). A 73-Year-Old Woman With Pulseless Electrical Activity Arrest. <em>Chest</em>,<em> 160</em>(6), e665-e667. <a href="https://doi.org/10.1016/j.chest.2021.03.075" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.chest.2021.03.075</a></li>
<li>Koleilat, I., Galen, B., Choinski, K., Hatch, A. N., Jones, D. B., Billett, H., Indes, J., & Lipsitz, E. (2021). Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019. <em>J Vasc Surg Venous Lymphat Disord</em>,<em> 9</em>(1), 36-46. <a href="https://doi.org/10.1016/j.jvsv.2020.06.012" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.jvsv.2020.06.012</a></li>
<li>Nauka, P. C., & Galen, B. T. (2020). The Focused Assessment with Sonography in Cancer (FASC) Examination. <em>Pocus j</em>,<em> 5</em>(2), 42-45. <a href="https://doi.org/10.24908/pocus.v5i2.14428" target="_blank" rel="noopener noreferrer">https://doi.org/10.24908/pocus.v5i2.14428</a></li>
<li>Merkin, R., Kruger, A., Bhardwaj, G., Kajita, G. R., Shapiro, L., & Galen, B. T. (2020). Internal Medicine Resident Work Absence During the COVID-19 Pandemic at a Large Academic Medical Center in New York City. <em>J Grad Med Educ</em>,<em> 12</em>(6), 682-685. <a href="https://doi.org/10.4300/jgme-d-20-00657.1" target="_blank" rel="noopener noreferrer">https://doi.org/10.4300/jgme-d-20-00657.1</a></li>
</ol>